{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T22:58:52Z","timestamp":1769122732343,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012626","name":"Andrew David Heitman Foundation","doi-asserted-by":"publisher","award":["1200 236980"],"award-info":[{"award-number":["1200 236980"]}],"id":[{"id":"10.13039\/100012626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS083711"],"award-info":[{"award-number":["NS083711"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS114526"],"award-info":[{"award-number":["R01NS114526"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5R01NS096730-04"],"award-info":[{"award-number":["5R01NS096730-04"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5R01AG026484"],"award-info":[{"award-number":["5R01AG026484"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00415-022-11333-2","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:04:10Z","timestamp":1661238250000},"page":"6589-6596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical and neuroimaging risk factors associated with the development of intracerebral hemorrhage while taking direct oral anticoagulants"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2313-977X","authenticated-orcid":false,"given":"Alvin S.","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"G\u00f6k\u00e7al","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2958-3484","authenticated-orcid":false,"given":"Robert W.","family":"Regenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua N.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Taylor","family":"Kimberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee H.","family":"Schwamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Rosand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Edip","family":"Gurol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"11333_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/eurheartj\/ehw658","volume":"38","author":"K Gadsb\u00f8ll","year":"2017","unstructured":"Gadsb\u00f8ll K, Staerk L, Fosb\u00f8l EL et al (2017) Increased use of oral anticoagulants in patients with atrial fibrillation: Temporal trends from 2005 to 2015 in Denmark. Eur Heart J 38:899\u2013906. https:\/\/doi.org\/10.1093\/eurheartj\/ehw658","journal-title":"Eur Heart J"},{"key":"11333_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1161\/CIRCULATIONAHA.118.036046","volume":"138","author":"TF Chao","year":"2018","unstructured":"Chao TF, Chiang CE, Lin YJ et al (2018) Evolving changes of the use of oral anticoagulants and outcomes in patients with newly diagnosed atrial fibrillation in Taiwan. Circulation 138:1485\u20131487","journal-title":"Circulation"},{"key":"11333_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"key":"11333_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jama.2017.21917","volume":"319","author":"T Inohara","year":"2018","unstructured":"Inohara T, Xian Y, Liang L et al (2018) Association of intracerebral hemorrhage among patients taking non-vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality. JAMA 319:463. https:\/\/doi.org\/10.1001\/jama.2017.21917","journal-title":"JAMA"},{"key":"11333_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/ene.13742","volume":"25","author":"AH Katsanos","year":"2018","unstructured":"Katsanos AH, Schellinger PD, K\u00f6hrmann M et al (2018) Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis. Eur J Neurol 25:1299\u20131302. https:\/\/doi.org\/10.1111\/ene.13742","journal-title":"Eur J Neurol"},{"key":"11333_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139\u20131151. https:\/\/doi.org\/10.1056\/NEJMoa0905561","journal-title":"N Engl J Med"},{"key":"11333_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J et al (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883\u2013891. https:\/\/doi.org\/10.1056\/NEJMoa1009638","journal-title":"N Engl J Med"},{"key":"11333_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ et al (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981\u2013992. https:\/\/doi.org\/10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"11333_CR9","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/nejmoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E et al (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093\u20132104. https:\/\/doi.org\/10.1056\/nejmoa1310907","journal-title":"N Engl J Med"},{"key":"11333_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jamaneurol.2015.3682","volume":"73","author":"JC Purrucker","year":"2016","unstructured":"Purrucker JC, Haas K, Rizos T et al (2016) Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurol 73:169. https:\/\/doi.org\/10.1001\/jamaneurol.2015.3682","journal-title":"JAMA Neurol"},{"key":"11333_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1212\/WNL.0000000000003886","volume":"88","author":"D Wilson","year":"2017","unstructured":"Wilson D, Seiffge DJ, Traenka C et al (2017) Outcome of intracerebral hemorrhage associated with different oral anticoagulants. Neurology 88:1693\u20131700. https:\/\/doi.org\/10.1212\/WNL.0000000000003886","journal-title":"Neurology"},{"key":"11333_CR12","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/STROKEAHA.118.023492","volume":"50","author":"ST Gerner","year":"2019","unstructured":"Gerner ST, Kuramatsu JB, Sembill JA et al (2019) Characteristics in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage. Stroke 50:1392\u20131402. https:\/\/doi.org\/10.1161\/STROKEAHA.118.023492","journal-title":"Stroke"},{"key":"11333_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s11239-013-0899-7","volume":"35","author":"M Shoeb","year":"2013","unstructured":"Shoeb M, Fang MC (2013) Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis 35:312\u2013319. https:\/\/doi.org\/10.1007\/s11239-013-0899-7","journal-title":"J Thromb Thrombolysis"},{"key":"11333_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11886-013-0425-8","volume":"15","author":"KE Haley","year":"2013","unstructured":"Haley KE, Greenberg SM, Gurol ME (2013) Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies? Curr Cardiol Rep 15:425. https:\/\/doi.org\/10.1007\/s11886-013-0425-8","journal-title":"Curr Cardiol Rep"},{"key":"11333_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","volume":"17","author":"D Wilson","year":"2018","unstructured":"Wilson D, Ambler G, Shakeshaft C et al (2018) Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol 17:539\u2013547. https:\/\/doi.org\/10.1016\/S1474-4422(18)30145-5","journal-title":"Lancet Neurol"},{"key":"11333_CR16","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/WNL.0000000000003866","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Xiong L et al (2017) Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. Neurology 88:1607\u20131614. https:\/\/doi.org\/10.1212\/WNL.0000000000003866","journal-title":"Neurology"},{"key":"11333_CR17","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/brain\/awv162","volume":"138","author":"A Charidimou","year":"2015","unstructured":"Charidimou A, Linn J, Vernooij MW et al (2015) Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain 138:2126\u20132139. https:\/\/doi.org\/10.1093\/brain\/awv162","journal-title":"Brain"},{"key":"11333_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1212\/01.wnl.0000339060.11702.dd","volume":"72","author":"S-H Lee","year":"2009","unstructured":"Lee S-H, Ryu W-S, Roh J-K (2009) Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 72:171\u2013176. https:\/\/doi.org\/10.1212\/01.wnl.0000339060.11702.dd","journal-title":"Neurology"},{"key":"11333_CR19","unstructured":"Nalichowski R, Keogh D, Chueh HC, Murphy SN (2006) Calculating the benefits of a Research Patient Data Repository. In: AMIA Annu. Symp. Proc. https:\/\/pubmed.ncbi.nlm.nih.gov\/17238663\/. Accessed 23 Jun 2021"},{"key":"11333_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1212\/01.wnl.0000191403.95453.6a","volume":"66","author":"ME Gurol","year":"2006","unstructured":"Gurol ME, Irizarry MC, Smith EE et al (2006) Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology 66:23\u201329. https:\/\/doi.org\/10.1212\/01.wnl.0000191403.95453.6a","journal-title":"Neurology"},{"key":"11333_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"11333_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822\u2013838. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8","journal-title":"Lancet Neurol"},{"key":"11333_CR23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S1474-4422(17)30196-5","volume":"16","author":"SJ van Veluw","year":"2017","unstructured":"van Veluw SJ, Shih AY, Smith EE et al (2017) Detection, risk factors, and functional consequences of cerebral microinfarcts. Lancet Neurol 16:730\u2013740. https:\/\/doi.org\/10.1016\/S1474-4422(17)30196-5","journal-title":"Lancet Neurol"},{"key":"11333_CR24","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/wnl.43.9.1683","volume":"43","author":"F Fazekas","year":"1993","unstructured":"Fazekas F, Kleinert R, Offenbacher H et al (1993) Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 43:1683\u20131689. https:\/\/doi.org\/10.1212\/wnl.43.9.1683","journal-title":"Neurology"},{"key":"11333_CR25","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1212\/WNL.0000000000002362","volume":"86","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Boulouis G, Haley K et al (2016) White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 86:505\u2013511. https:\/\/doi.org\/10.1212\/WNL.0000000000002362","journal-title":"Neurology"},{"key":"11333_CR26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1212\/WNL.0000000000004007","volume":"88","author":"M Pasi","year":"2017","unstructured":"Pasi M, Boulouis G, Fotiadis P et al (2017) Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease. Neurology 88:2162\u20132168. https:\/\/doi.org\/10.1212\/WNL.0000000000004007","journal-title":"Neurology"},{"key":"11333_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.004","volume":"28","author":"AS Das","year":"2019","unstructured":"Das AS, Regenhardt RW, Feske SK, Gurol ME (2019) Treatment approaches to lacunar stroke. J Stroke Cerebrovasc Dis 28:2055\u20132078","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"11333_CR28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1212\/WNL.0000000000003746","volume":"88","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Pasi M et al (2017) MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 88:1157\u20131164. https:\/\/doi.org\/10.1212\/WNL.0000000000003746","journal-title":"Neurology"},{"key":"11333_CR29","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/WNL.0000000000004665","volume":"89","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Roongpiboonsopit D et al (2017) Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology 89:2128\u20132135. https:\/\/doi.org\/10.1212\/WNL.0000000000004665","journal-title":"Neurology"},{"key":"11333_CR30","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3181dad605","volume":"74","author":"J Linn","year":"2010","unstructured":"Linn J, Halpin A, Demaerel P et al (2010) Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 74:1346\u20131350. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dad605","journal-title":"Neurology"},{"key":"11333_CR31","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN et al (2014) Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology 83:1228\u20131234. https:\/\/doi.org\/10.1212\/WNL.0000000000000837","journal-title":"Neurology"},{"key":"11333_CR32","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1161\/STROKEAHA.112.650614","volume":"43","author":"RG Hart","year":"2012","unstructured":"Hart RG, Diener HC, Yang S et al (2012) Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: The RE-LY trial. Stroke 43:1511\u20131517. https:\/\/doi.org\/10.1161\/STROKEAHA.112.650614","journal-title":"Stroke"},{"key":"11333_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1161\/STROKEAHA.113.004506","volume":"45","author":"GJ Hankey","year":"2014","unstructured":"Hankey GJ, Stevens SR, Piccini JP et al (2014) Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation. Stroke 45:1304\u20131312. https:\/\/doi.org\/10.1161\/STROKEAHA.113.004506","journal-title":"Stroke"},{"key":"11333_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000015958","volume":"9","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, Pearce LA (1999) Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovasc Dis 9:215\u2013217. https:\/\/doi.org\/10.1159\/000015958","journal-title":"Cerebrovasc Dis"},{"key":"11333_CR35","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1161\/01.STR.0000141933.75462.c2","volume":"35","author":"TI Shireman","year":"2004","unstructured":"Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF (2004) Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 35:2362\u20132367. https:\/\/doi.org\/10.1161\/01.STR.0000141933.75462.c2","journal-title":"Stroke"},{"key":"11333_CR36","doi-asserted-by":"publisher","first-page":"e2192","DOI":"10.1212\/WNL.0000000000010788","volume":"95","author":"JG Best","year":"2020","unstructured":"Best JG, Barbato C, Ambler G et al (2020) Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage. Neurology 95:e2192\u2013e2199. https:\/\/doi.org\/10.1212\/WNL.0000000000010788","journal-title":"Neurology"},{"key":"11333_CR37","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1161\/01.STR.24.11.1655","volume":"24","author":"I Dawson","year":"1993","unstructured":"Dawson I, Hajo van Bockel JH, Ferrari MD et al (1993) Ischemic and hemorrhagic stroke in patients on oral anticoagulants after reconstruction for chronic lower limb ischemia. Stroke 24:1655\u20131663. https:\/\/doi.org\/10.1161\/01.STR.24.11.1655","journal-title":"Stroke"},{"key":"11333_CR38","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar N, Gao P, Kondapally Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215\u20132222. https:\/\/doi.org\/10.1016\/S0140-6736(10)60484-9","journal-title":"Lancet"},{"key":"11333_CR39","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1212\/WNL.0000000000003031","volume":"87","author":"M Boulanger","year":"2016","unstructured":"Boulanger M, Poon MTC, Wild SH, Al-Shahi Salman R (2016) Association between diabetes mellitus and the occurrence and outcome of intracerebral hemorrhage. Neurology 87:870\u2013878. https:\/\/doi.org\/10.1212\/WNL.0000000000003031","journal-title":"Neurology"},{"key":"11333_CR40","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/CIRCOUTCOMES.114.001606","volume":"8","author":"J \u00d6gren","year":"2015","unstructured":"\u00d6gren J, Irewall AL, Bergstr\u00f6m L, Mooe T (2015) Intracranial hemorrhage after ischemic stroke: incidence, time trends, and predictors in a Swedish Nationwide cohort of 196 765 patients. Circ Cardiovasc Qual Outcomes 8:413\u2013420. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.114.001606","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"11333_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5853\/jos.2020.04770","volume":"23","author":"S Cho","year":"2021","unstructured":"Cho S, Rehni AK, Dave KR (2021) Tobacco use: a major risk factor of intracerebral hemorrhage. J Stroke 23:37\u201350. https:\/\/doi.org\/10.5853\/jos.2020.04770","journal-title":"J Stroke"},{"key":"11333_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5853\/jos.2018.03608","volume":"21","author":"AS Das","year":"2019","unstructured":"Das AS, Regenhardt RW, Vernooij MW et al (2019) Asymptomatic cerebral small vessel disease: insights from population-based studies. J Stroke 21:121\u2013138. https:\/\/doi.org\/10.5853\/jos.2018.03608","journal-title":"J Stroke"},{"key":"11333_CR43","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/STROKEAHA.120.031827","volume":"52","author":"M Paciaroni","year":"2021","unstructured":"Paciaroni M, Agnelli G, Giustozzi M et al (2021) Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on non-vitamin K antagonist oral anticoagulants for stroke prevention. Stroke 52:1450\u20131454. https:\/\/doi.org\/10.1161\/STROKEAHA.120.031827","journal-title":"Stroke"},{"key":"11333_CR44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0b013e3182a08f2c","volume":"81","author":"A Charidimou","year":"2013","unstructured":"Charidimou A, J\u00e4ger RH, Fox Z et al (2013) Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 81:626\u2013632. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a08f2c","journal-title":"Neurology"},{"key":"11333_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/STROKEAHA.117.016990","volume":"49","author":"SM Greenberg","year":"2018","unstructured":"Greenberg SM, Charidimou A (2018) Diagnosis of cerebral amyloid angiopathy. Stroke 49:491\u2013497. https:\/\/doi.org\/10.1161\/STROKEAHA.117.016990","journal-title":"Stroke"},{"issue":"7","key":"11333_CR46","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1212\/WNL.55.7.947","volume":"55","author":"J Rosand","year":"2000","unstructured":"Rosand J, Hylek EM, O'Donnell HC, Greenberg SM (2000) Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55(7):947\u2013951","journal-title":"Neurology"},{"key":"11333_CR47","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.06.037","volume":"27","author":"R Zand","year":"2018","unstructured":"Zand R, Shahjouei S, Tsivgoulis G et al (2018) Cerebral microbleeds are associated with higher mortality among ischemic stroke patients. J Stroke Cerebrovasc Dis 27:3036\u20133042. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.06.037","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"11333_CR48","doi-asserted-by":"publisher","first-page":"E1013","DOI":"10.1212\/WNL.0000000000013247","volume":"98","author":"JR Magid-Bernstein","year":"2022","unstructured":"Magid-Bernstein JR, Li Y, Cho SM et al (2022) Cerebral microbleeds and acute hematoma characteristics in the ATACH-2 and MISTIE III Trials. Neurology 98:E1013\u2013E1020. https:\/\/doi.org\/10.1212\/WNL.0000000000013247","journal-title":"Neurology"},{"key":"11333_CR49","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ana.410380219","volume":"38","author":"SM Greenberg","year":"1995","unstructured":"Greenberg SM, William Rebeck G, Vonsattel JPG et al (1995) Apolipoprotein E \u03f54 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38:254\u2013259. https:\/\/doi.org\/10.1002\/ana.410380219","journal-title":"Ann Neurol"},{"key":"11333_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/ANA.410410607","volume":"41","author":"JAR Nicoll","year":"1997","unstructured":"Nicoll JAR, Burnett C, Love S et al (1997) High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41:716\u2013721. https:\/\/doi.org\/10.1002\/ANA.410410607","journal-title":"Ann Neurol"},{"key":"11333_CR51","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1212\/WNL.0000000000000816","volume":"83","author":"GJ Falcone","year":"2014","unstructured":"Falcone GJ, Radmanesh F, Brouwers HB et al (2014) APOE \u03b5 variants increase risk of warfarin-related intracerebral hemorrhage. Neurology 83:1139. https:\/\/doi.org\/10.1212\/WNL.0000000000000816","journal-title":"Neurology"},{"key":"11333_CR52","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest 138:1093\u20131100. https:\/\/doi.org\/10.1378\/chest.10-0134","journal-title":"Chest"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11333-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11333-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T12:07:39Z","timestamp":1667131659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11333-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["11333"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11333-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Gurol received research grants to his hospital from AVID, Pfizer and Boston Scientific Corporation. Dr. Goldstein received research grants to his hospital from Pfizer, Takeda, and Octapharma, and consulting from Alexion, CSL Behring, NControl, and Cayuga. The other authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approval for this study was granted by our hospital\u2019s institutional review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Consent to participate was waived for this study given its retrospective nature.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent to publication was waived for this study given its retrospective nature.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}]}}